We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The deal gives BMS mavacamten, MyoKardia’s investigational treatment for obstructive hypertrophic cardiomyopathy, a chronic heart disease afflicting up to 200,000 individuals in the U.S. and the EU. Read More
AbbVie, Abbott Laboratories, Unimed Pharmaceuticals and Besins Healthcare are off the hook for $448 million they would have had to pay to the Federal Trade Commission (FTC), thanks to a favorable ruling by a federal appeals court. Read More
The Serum Institute of India (SII) has announced it will produce up to 100 million additional COVID-19 vaccine doses through its collaboration with the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance to supply India and lower income nations. Read More
J&J last week began the largest phase 3 trial of a COVID-19 vaccine to date, in which it aims to enroll 60,000 participants across eight countries. Read More
A federal court of appeals has rejected a novel plan that would have brought every community in the U.S. into a class-action suit along with 1,300 cities and counties that are suing opioid makers. Read More
Humanigen has teamed up with Massachusetts-based Thermo Fisher Scientific, which will help manufacture the drug substance for Humanigen’s COVID-19 monoclonal antibody lenzilumab. Read More